Nemaura Medical Inc expected to post a loss of 17  cents a share - Earnings Preview

Nemaura Medical

13/08/2022 24:50

* Nemaura Medical Inc  NMRD.OQ   NMRD.O  is expected to show
a
rise in quarterly revenue when it reports  results on August 15
(estimated). 
    * The New York City-based  company is expected to report
revenue
of $450 thousand, according to the mean estimate from 2
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Nemaura Medical Inc
is
for a loss of 17 cents per share. For the same quarter last
year, the company reported a loss of 14 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Nemaura
Medical
Inc is $12​, above​ its last closing price of $2.37. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.14       -0.14      -0.15     Missed  -9.8
 Dec. 31 2022  -0.14       -0.14      -0.15     Missed  -7.1
 Sep. 30 2021  -0.11       -0.11      -0.15     Missed  -36.4​
 Jun. 30 2021  -0.08       -0.08      -0.14     Missed  -75
 ​​Mar.                    -0.08      -0.09     Missed  -12.5
 31 2021                                                
                                                        ​
 This summary was machine generated August 12 at 23:50 GMT.  All
figures in US dollars  unless otherwise stated